New online tool aims to ease tough transition for teens with diabetes

NCT ID NCT05910840

First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 37 times

Summary

This study tests whether an online training and peer support platform (Support-t) helps teens with type 1 diabetes prepare for the move from pediatric to adult healthcare. About 200 teens aged 14-16 will either use the platform plus usual care or just usual care. The main goal is to see if the platform helps keep blood sugar levels stable over 18 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier Universitaire de Québec

    NOT_YET_RECRUITING

    Québec, Canada

    Contact Email: •••••@•••••

  • Centre Hospitalier Universitaire de Sherbrooke

    NOT_YET_RECRUITING

    Sherbrooke, Canada

    Contact Email: •••••@•••••

  • Clinique de pédiatrie Le Copain-Hôpital de Gatineau

    NOT_YET_RECRUITING

    Gatineau, Canada

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Montreal Children's Hospital - McGill University Health Centre

    RECRUITING

    Montreal, Canada

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

autoimmune disease diabetes mellitus endocrine system disorder glucose metabolism disease immune system disorder metabolic disease type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.